Transformative gene modulation platform with its proprietary, multi-functional Cas proteins. Spin-out from Univ of Tokyo. IPOed in 2020
Total raised: $30M
Investors 2
Date | Name | Website |
- | Fast Track... | fti-jp.com |
- | Fast Track... | us.fasttra... |
Funding Rounds 2
Date | Series | Amount | Investors |
10.04.2019 | Series B | $15M | - |
08.08.2018 | Series B | $15M | - |
Mentions in press and media 4
Date | Title | Description | Source |
11.04.2019 | Insurance Tech Startup Lemonade Raises $300 Million in Fundi... | MAKING LEMONADE Softbank is doubling down on Lemonade. Paid Content You can't secure what you can'... | fortune.co... |
10.04.2019 | EdiGENE Raises $15M in Series B Funding | EdiGENE, a Tokyo, Japan based biotechnology company developing new CRISPR based therapies for treatm... | finsmes.co... |
10.04.2019 | Daily funding roundup - April 10th, 2019 | Cullgen received $16M; CleverTap raised $26M; Shift secured $40M; ShopBack landed $45M Bump: Bump i... | vator.tv/n... |
08.08.2018 | Genome Editing Biotech Company EdiGene Raises $15M in Series... | EdiGene Inc., a Beijing, China-based genome editing biotech company, raised approximately $15M in a ... | finsmes.co... |